Singapore's M&L Healthcare sells new diabetes-related treatment to Nasdaq firm for $334 million
M&L Healthcare is a family-owned investment fund founded by shipping tycoon Michael Kum and his wife Lynda. Read more at straitstimes.com.
Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
M&L Healthcare is a family-owned investment fund founded by shipping tycoon Michael Kum and his wife Lynda. Read more at straitstimes.com.
LimFlow will receive $250 million in cash and be eligible to receive up to $165 million in additional payments.
Sofinnova Partners, acting on behalf of the Sofinnova Crossover I SLP fund, has declared to the AMF that on November 21 it exceeded the thresholds of 20% of the capital and voting rights in GenSight...
LONDON and SHANGHAI, China, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announce that they have entered into a license agreement under which Myricx will have exclusive
SIOUX FALLS, S.D., Nov. 20, 2023 -- SAB Biotherapeutics , a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte...